Wall Street Experts
ver. ZuMIgo(08/25)
Atai Life Sciences N.V.
Rachunek Zysków i Strat
Przychody TTM (mln): 0
EBIT TTM (mln): -125
index |
0 |
1 |
2 |
3 |
4 |
5 |
Rok finansowy |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Przychód (mln) |
0 |
0 |
20 |
0 |
0 |
0 |
Przychód Δ r/r |
0.0% |
0.0% |
inf% |
-98.9% |
34.8% |
-1.9% |
Marża brutto |
-inf% |
-inf% |
99.8% |
27.9% |
-1.6% |
100.0% |
EBIT (mln) |
2 |
-104 |
-136 |
-145 |
-125 |
-103 |
EBIT Δ r/r |
0.0% |
-6717.7% |
30.4% |
6.6% |
-13.3% |
-18.2% |
EBIT (%) |
0.0% |
0.0% |
-666.5% |
-62140.3% |
-39958.9% |
-33341.2% |
Koszty finansowe (mln) |
0 |
0 |
0 |
2 |
3 |
3 |
EBITDA (mln) |
2 |
-98 |
-105 |
-144 |
-125 |
-145 |
EBITDA(%) |
0.0% |
0.0% |
-514.6% |
-61833.9% |
-39857.3% |
-47015.6% |
Podatek (mln) |
0 |
0 |
-4 |
6 |
1 |
0 |
Zysk Netto (mln) |
-17 |
-102 |
-133 |
-141 |
-40 |
-149 |
Zysk netto Δ r/r |
0.0% |
484.3% |
29.9% |
6.6% |
-71.6% |
271.1% |
Zysk netto (%) |
0.0% |
0.0% |
-650.8% |
-60691.4% |
-12810.2% |
-48464.0% |
EPS |
-3.23 |
-17.57 |
-0.83 |
-0.91 |
-0.25 |
-0.93 |
EPS (rozwodnione) |
-3.23 |
-17.57 |
-0.83 |
-0.91 |
-0.25 |
-0.93 |
Ilośc akcji (mln) |
5 |
6 |
161 |
156 |
159 |
160 |
Ważona ilośc akcji (mln) |
5 |
6 |
161 |
156 |
159 |
160 |
Waluta |
USD |
USD |
USD |
USD |
USD |
USD |